Sente, Inc., a company that leverages its expertise is founded on a platform of biotechnology to deliver luxury, skin care products. As a pioneer in developing skincare products based on Glycosaminoglycans, Sente is the only line of aesthetic products created with a patented low molecular weight heparan sulfate analog, HSA™.
Established through innovative ideas collaborated with leading scientists around the globe, Sente offers biotechnology and groundbreaking drug developments to the world of skincare. Going forth with evolving research and scientific technology, Sente fully believes that rigorous clinical studies must continue to motivate the growth of topical skin care solutions.